Eric discusses the innovative approach of Theranos, a company aiming to revolutionize lab medicine by conducting routine assays with just one droplet of blood. He highlights the potential of microfluidics and the future possibility of smartphone labs. The conversation explores the drawbacks of traditional lab medicine and the need for accessible and timely test results.
